IC‐P‐088: Effects of 12 months of treatment with the PPAR<i>γ</i> agonist rosiglitazone on brain glucose metabolism in Alzheimer's disease: A <sup>18</sup>F‐FDG PET studyEugenii A. Rabiner, Paul M. Matthews, Marina Zvartau‐Hind et al.|Alzheimer s & Dementia|2009Cited by 7
P1‐112: Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's Disease: A <sup>18</sup>F‐FDG PET studyEugenii A. Rabiner, Paul M. Matthews, Sofia Tzimopoulou et al.|Alzheimer s & Dementia|2009Cited by 3